New Arrival China C Diff Vancomycin Treatment - D-Amino Acids Series for Solid Phase Synthesis – Gentolex
New Arrival China C Diff Vancomycin Treatment - D-Amino Acids Series for Solid Phase Synthesis – Gentolex Detail:
Product Detail
|
No |
Products |
CAS No. |
Key quality indicator |
||||
|
Purity |
Isomer |
Specific Impurity |
*Max1 |
Moisture |
|||
|
1 |
Fmoc-D-Ala-OH.H2O | 79990-15-1 |
≥99.5% |
≤0.1% |
≤0.1% |
≤0.2% |
≤6.5% |
|
2 |
Fmoc-3-(2-naphthyl)-D-Ala-OH | 138774-94-4 |
≥99.0% |
≤0.2% |
≤0.3% |
≤0.3% |
≤1.0% |
|
3 |
Ac-3-(2-naphthyl)-D-Ala-OH | 37440-01-0 |
≥99.0% |
≤0.2% |
≤0.3% |
≤0.3% |
≤1.0% |
|
4 |
Fmoc-3-(3-pyridinyl)-D-Ala-OH | 142994-45-4 |
≥99.0% |
≤0.2% |
≤0.3% |
≤0.3% |
≤1.0% |
|
5 |
Fmoc-D-Aph(tBuCbm)-OH | 1433975-21-3 |
≥99.0% |
≤0.2% |
≤0.3% |
≤0.3% |
≤1.0% |
|
6 |
Fmoc-D-Aph(Cbm)-OH | 324017-22-3 |
≥99.0% |
≤0.2% |
≤0.3% |
≤0.3% |
≤1.0% |
|
7 |
Fmoc-D-Aph(Hor)-OH | NA |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
8 |
Fmoc-Aph(D-Hor)-OH | NA |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
9 |
Fmoc-D-Arg(pbf)-OH | 187618-60-6 |
≥99.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤2.0% |
|
10 |
Fmoc-D-Arg (NO2)-OH | 160347-94-4 |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤2.0% |
|
11 |
Fmoc-D-HomoArg(pbf)-OH | 401915-53-5 |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤2.0% |
|
12 |
Fmoc-D-HomoArg(Et)2-OH | NA |
≥95.0% |
≤0.5% |
≤1.0% |
≤2.0% |
≤2.0% |
|
13 |
Fmoc-D-Asn(Trt)-OH | 180570-71-2 |
≥98.5% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
14 |
Fmoc-D-Asp(OtBu)-OH | 112883-39-3 |
≥98.5% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
15 |
Fmoc-D-Asp-OtBu | 34098-70-7 |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
16 |
Fmoc-D-Asp(OAll)-OH | 177609-12-0 |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
17 |
Fmoc-D-Cit-OH | 200344-33-8 |
≥99.5% |
≤0.1% |
≤0.1% |
≤0.2% |
≤1.0% |
|
18 |
Fmoc-D-Cys(Trt)-OH | 167015-11-4 |
≥98.5% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
19 |
Fmoc-D-Cys(Acm)-OH | 168300-88-7 |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
20 |
Fmoc-D-Cys(Mmt)-OH | 1198791-73-9 |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
21 |
Fmoc-D-Gln(Trt)-OH | 200623-62-7 |
≥98.5% |
≤0.2% |
≤0.3% |
≤0.5% |
≤2.0% |
|
22 |
Fmoc-D-Glu(OtBu)-OH.H2O | 104091-08-9 |
≥98.5% |
≤0.2% |
≤0.3% |
≤0.5% |
≤5.0% |
|
23 |
Fmoc-D-Glu-OtBu | 109745-15-5 |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
24 |
H-D-Glu-OtBu | 25456-76-2 |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
25 |
Fmoc-D-His(Trt)-OH | 135610-90-1 |
≥98.5% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
26 |
Boc-D-His(Trt)-OH | 393568-74-6 |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
27 |
Fmoc-D-His(Bzl)-OH | 1417638-37-9 |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
28 |
Fmoc-D-Ile-OH | 143688-83-9 |
≥98.5% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
29 |
Fmoc-D-Allo-Ile-OH | 118904-37-3 |
≥98.5% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
30 |
Fmoc-D-Leu-OH | 114360-54-2 |
≥99.5% |
≤0.1% |
≤0.1% |
≤0.2% |
≤1.0% |
|
31 |
Fmoc-D-Lys(Boc)-OH | 92122-45-7 |
≥98.5% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
32 |
Fmoc-D-Lys(Alloc)-OH | 214750-75-1 |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
33 |
Fmoc-D-Lys(ivDde)-OH | 1272755-33-5 |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
34 |
Fmoc-D-Lys(Mmt)-OH | 198544-94-4 |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
35 |
Fmoc-D-Lys(iPr,Boc)-OH | NA |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
36 |
Fmoc-D-Lys(nicotinoyl)-OH | 252049-12-0 |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
37 |
Fmoc-D-Met-OH | 112883-40-6 |
≥98.5% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
38 |
Fmoc-D-Orn(Boc)-OH | 118476-89-4 |
≥98.5% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
39 |
Fmoc-D-Phe-OH | 86123-10-6 |
≥99.5% |
≤0.1% |
≤0.1% |
≤0.2% |
≤1.0% |
|
40 |
Fmoc-4-chloro-D-Phe-OH | 142994-19-2 |
≥99.0% |
≤0.2% |
≤0.3% |
≤0.3% |
≤1.0% |
|
41 |
Fmoc-D-Pro-OH.H2O | 101555-62-8 |
≥98.5% |
≤0.2% |
≤0.3% |
≤0.5% |
≤6.0% |
|
42 |
D-Pyr-OH | 4042-36-8 |
≥98.5% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
43 |
Fmoc-D-Ser(tBu)-OH | 128107-47-1 |
≥99.5% |
≤0.1% |
≤0.1% |
≤0.2% |
≤1.0% |
|
44 |
Fmoc-D-Ser(Trt)-OH | 212688-51-2 |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
45 |
Fmoc-D-Thr(tBu)-OH | 138797-71-4 |
≥98.5% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
46 |
Fmoc-D-Trp(Boc)-OH | 163619-04-3 |
≥98.5% |
≤0.2% |
≤0.3% |
≤0.5% |
≤2.0% |
|
47 |
Fmoc-2-methyl-D-Trp-OH | 196808-79-4 |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤2.0% |
|
48 |
Fmoc-D-Tyr(tBu)-OH | 118488-18-9 |
≥98.5% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
49 |
Fmoc-D-Tyr(Et)-OH | 162502-65-0 |
≥99.5% |
≤0.1% |
≤0.1% |
≤0.2% |
≤1.0% |
|
50 |
Fmoc-D-Tyr(Me)-OH | 201335-88-8 |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
51 |
Fmoc-N-Me-D-Tyr(tBu)-OH | 196808-79-4 |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
52 |
Fmoc-D-Tyr (Bzl)-OH | 138775-48-1 |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
53 |
Fmoc-D-Val-OH | 84624-17-9 |
≥98.5% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
54 |
Fmoc-D-Hyp(tBu)-OH | 464193-92-8 |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
55 |
Fmoc-D-Thi-OH | 201532-42-5 |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
56 |
Fmoc-D-Tic-OH | 130309-33-0 |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
57 |
Fmoc-D-Oic-OH | 130309-37-4 |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
58 |
Boc-D-His(Trt)-Aib-OH | NA |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
59 |
Fmoc-D-Glu(OtBu)-Gly-OH | NA |
≥95.0% |
≤0.5% |
≤1.0% |
≤2.0% |
≤1.0% |
|
60 |
Boc-D-His(Trt)-Aib-Glu(OtBu)-Gly-OH | NA |
≥95.0% |
≤0.5% |
≤1.0% |
≤2.0% |
≤1.0% |
|
61 |
Boc-His(Trt)-Aib-D-Glu(OtBu)-Gly-OH | NA |
≥95.0% |
≤0.5% |
≤1.0% |
≤2.0% |
≤1.0% |
|
62 |
Boc-D-His(Trt)-Aib-D-Glu(OtBu)-Gly-OH | NA |
≥95.0% |
≤0.5% |
≤1.0% |
≤2.0% |
≤1.0% |
|
63 |
Fmoc-D-Arg(pbf)-Gly-OH | NA |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
64 |
Fmoc-D-Ala-Ala-OH | NA |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
65 |
Fmoc-Ala-D-Ala-OH | NA |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
66 |
Fmoc-D-Ala-D-Ala-OH | NA |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
67 |
Fmoc-D-Lys(Palm-Glu-OtBu)-OH | NA |
≥95.0% |
≤0.5% |
≤1.0% |
≤2.0% |
≤1.0% |
|
68 |
Fmoc-Lys(Palm-D-Glu-OtBu)-OH | NA |
≥95.0% |
≤0.5% |
≤1.0% |
≤2.0% |
≤1.0% |
|
69 |
Fmoc-D-Lys(Palm-D-Glu-OtBu)-OH | NA |
≥95.0% |
≤0.5% |
≤1.0% |
≤2.0% |
≤1.0% |
|
70 |
Octa(OtBu)-D-Glu-OtBu | NA |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
71 |
Octa(OtBu)-D-Glu(ɑ-OtBu)-AEEA-AEEA-OH | NA |
≥95.0% |
≤0.5% |
≤1.0% |
≤2.0% |
≤1.0% |
*Max1 = Max Unknown Purity
Other Info:
- Acetic Acid: ≤0.02% (All Products)
- Ethyl Acetate: ≤0.5% (All Products)
- Alcohol: ≤0.5% (All Products)
Purified Water
Purified water is used in production and equipment cleaning for API. Purified water is generated by city water, processed through pre-treatment (multi-media filter, softener, activated carbon filter, etc.) and reverse osmosis (RO), and then the purified water is stored in the tank. The water is constantly circulating at 25±2℃ with flow rate of 1.2m/s.
Product detail pictures:
Related Product Guide:
Our company since its inception, always regards product quality as enterprise life, continuously improve production technology, improve product quality and continuously strengthen enterprise total quality management, in strict accordance with the national standard ISO 9001:2000 for New Arrival China C Diff Vancomycin Treatment - D-Amino Acids Series for Solid Phase Synthesis – Gentolex , The product will supply to all over the world, such as: Costa rica, Porto, Jordan, They are sturdy modeling and promoting effectively all over the world. Never ever disappearing major functions within a quick time, it's a have to in your case of fantastic good quality. Guided by the principle of Prudence, Efficiency, Union and Innovation. the corporation. ake an excellent efforts to expand its international trade, raise its organization. rofit and raise its export scale. We've been confident that we've been going to have a bright prospect and to be distributed all over the world in the years to come.
By Dale from Manchester - 2017.02.18 15:54
The enterprise has a strong capital and competitive power, product is sufficient, reliable, so we have no worries on cooperating with them.
By Melissa from Houston - 2017.09.09 10:18
